[Edaily Starin Reporter Choi Hee-jae ] The group Tomorrow X Together will take the stage at the Jingle Ball Tour, a major U.S. year-end music festival, to meet with fans around the world. TOMORROW X TOGETHER (Photo courtesy of Big Hit Music) According to an announcement on the 25th (local time) by iHeartRadio, the largest media group in the U.S., Tomorrow X Together will perform at the “2026 iHeartRadio Jingle Ball Tour” taking place this December. Yeonjun has also been added to the lineup as a solo artist. This marks the group’s first-ever participation in the “Jingle Ball Tour.” The “Jingle Ball Tour” is a large-scale music festival held annually by iHeartRadio, touring major U.S. cities at the end of each year. This year’s lineup features Tomorrow X Together alongside other famous pop stars such as Olivia Rodrigo, the Jonas Brothers, SOMBR, Hilary Duff, Alex Warren, and Charlie Puth. Starting December 1 in Dallas/Fort Worth, the tour will continue through Los Angeles, Chicago, Detroit, New York, Boston, Washington, D.C., Philadelphia, and Nashville. Among these, Tomorrow X Together and Yeonjun will take the stage in New York on December 11, Boston on December 13, and Washington, D.C., on December 14. TOMORROW X TOGETHER will perform at the “2026 Global Citizen Festival” taking place on the 26th in New York’s Central Park. They will be the only Korean artist in this year’s lineup, meeting the audience there. In addition, the group will kick off their fifth world tour, “TOMORROW X TOGETHER WORLD TOUR STEAL THE WIND,” starting in Seoul from November 13–15. They will then perform in Macau from November 20–22.
A “semiconductor stock” frenzy swept through the stock market in the first half of this year. If you had held shares of SamsungElectronics and SK hynix 10 years ago, what would your return be today?
…
Mezzion Pharma Co., Ltd.(140410)has established an additional U.S. subsidiary dedicated exclusively to the development of treatments for autosomal dominant polycystic kidney disease (ADPKD).According …
Jin Yang-gon, Chairman of HLB INC., announced on the 24th via the company’s official YouTube channel that “Lirapugratinib” (RLY-4008), a treatment for bile duct cancer, had received approval from the …